Thc Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

H

• health-care (1)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• lung-cancer (2)

M

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

T

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)

Preliminary, open label, pilot study of add on oral Delta9 tetrahydrocannabinol in chronic post traumatic stress disorder. (2014)

Many patients with posttraumatic stress disorder (PTSD) achieve but partial remission with currenttreatments.Patients with unremitted PTSD show high rates of substance abuse. Marijuana is often used as compassion addon therapy for treatmentresistant PTSD. The present open-label study evaluates the tolerance and safety of orally absorbable ? (9) tetrahydrocannabinol (THC) for chronic PTSD. View study